Literature DB >> 20418368

Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization.

Gabor Kovacs1, Robert Maier, Elisabeth Aberer, Marianne Brodmann, Stefan Scheidl, Christian Hesse, Natascha Troester, Wolfgang Salmhofer, Rudolf Stauber, Florentine C Fuerst, Rene Thonhofer, Petra Ofner-Kopeinig, Ekkehard Gruenig, Horst Olschewski.   

Abstract

BACKGROUND: This study compared the results of exercise Doppler echocardiography (EDE) with right-sided heart catheterization (RHC) and evaluated the combination of EDE and cardiopulmonary exercise testing (CPET) as a screening method for early pulmonary vasculopathy in patients with connective tissue disease.
METHODS: Patients (N = 52) with connective tissue disease (predominantly systemic sclerosis) and without known pulmonary arterial hypertension underwent both EDE and CPET. If systolic pulmonary arterial pressure (SPAP) was > 40 mm Hg during exercise or peak oxygen uptake (Vo(2)) was < 75% predicted, RHC was suggested.
RESULTS: EDE showed an SPAP > 40 mm Hg during exercise in 26/52 patients. Additionally, CPET showed a peak Vo(2) < 75% predicted in 10/26 patients with SPAP <or= 40 mm Hg upon exercise. Accordingly, RHC was suggested to 36 patients. RHC was performed in 28 of these patients, revealing SPAP > 40 mm Hg in 25 patients (n = 1 at rest, n = 24 during exercise). SPAP values assessed by EDE showed no significant difference vs RHC at rest, 25 W, 50 W, and maximal exercise (difference [95% CI]: 0.3 [-2.7; 3.2], -1.3 [-7.1; 4.4], 0.9 [-7.7; 5.9], and -5.6 [-13.5; 2.2] mm Hg). Eight patients with exercise SPAP > 40 mm Hg had an exercise pulmonary arterial wedge pressure > 20 mm Hg, suggesting exercise-induced left ventricular diastolic dysfunction not detectable by EDE.
CONCLUSIONS: EDE appears to be a reasonable noninvasive method to detect SPAP increase during exercise in connective tissue disease. In combination with CPET, it may be a useful screening tool for early pulmonary vasculopathy, although RHC remains the gold standard for hemodynamic assessment. TRIAL REGISTRATION: clinicaltrials.gov; Identifier: NCT00609349 (Early Recognition of Pulmonary Arterial Hypertension).

Entities:  

Mesh:

Year:  2010        PMID: 20418368     DOI: 10.1378/chest.09-2099

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  Rest and exercise echocardiography for early detection of pulmonary hypertension.

Authors:  Kenya Kusunose; Hirotsugu Yamada
Journal:  J Echocardiogr       Date:  2015-11-30

Review 2.  Exercise-induced pulmonary hypertension: physiological basis and methodological concerns.

Authors:  Robert Naeije; Rebecca Vanderpool; Bishnu P Dhakal; Rajeev Saggar; Rajan Saggar; Jean-Luc Vachiery; Gregory D Lewis
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

3.  The right heart in athletes. Do we really have sufficient evidence for exercise-induced arrhythmogenic right ventricular cardiomyopathy?

Authors:  W Kindermann; D Corrado; J Scharhag
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-06

4.  Exercise Doppler echocardiography for the diagnosis of pulmonary hypertension: renewed interest and evolving roles.

Authors:  Yun Yun Go; Raluca Dulgheru; Tadafumi Sugimoto; Stella Marchetta; Cécile Oury; Patrizio Lancellotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Accuracy of Echocardiography to Estimate Pulmonary Artery Pressures With Exercise: A Simultaneous Invasive-Noninvasive Comparison.

Authors:  Annelieke C M J van Riel; Alexander R Opotowsky; Mário Santos; Jose M Rivero; Andy Dhimitri; Barbara J M Mulder; Berto J Bouma; Michael J Landzberg; Aaron B Waxman; David M Systrom; Amil M Shah
Journal:  Circ Cardiovasc Imaging       Date:  2017-04       Impact factor: 7.792

Review 6.  Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis.

Authors:  Gabor Kovacs; Horst Olschewski
Journal:  J Scleroderma Relat Disord       Date:  2019-05-24

7.  Noninvasive assessment of right heart function and hemodynamics during exercise in patients with pulmonary arterial hypertension.

Authors:  Michelle L Freeman; Carolyn Landolfo; Robert E Safford; Cesar A Keller; Michael G Heckman; Charles D Burger
Journal:  South Med J       Date:  2013-02       Impact factor: 0.954

8.  Systolic pulmonary artery pressure assessed during routine exercise Doppler echocardiography: insights of a real-world setting in patients with elevated pulmonary pressures.

Authors:  Susanne Korff; Patricia Enders-Gier; Lorenz Uhlmann; Matthias Aurich; Sebastian Greiner; Kristof Hirschberg; Hugo A Katus; Derliz Mereles
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

9.  Inhaled nitric oxide does not improve maximal oxygen consumption in endurance trained and untrained healthy individuals.

Authors:  Andrew R Brotto; Devin B Phillips; Victoria L Meah; Bryan A Ross; Desi P Fuhr; Rhys I Beaudry; Sean van Diepen; Michael K Stickland
Journal:  Eur J Appl Physiol       Date:  2022-01-22       Impact factor: 3.078

10.  Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.

Authors:  Vasiliki-Kalliopi Bournia; Anastasios Kallianos; Stylianos Panopoulos; Elias Gialafos; Lemonia Velentza; Panayiotis G Vlachoyiannopoulos; Petros P Sfikakis; Georgia Trakada
Journal:  Rheumatol Int       Date:  2021-06-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.